Posts

Be careful what you wish for: Method of treatment claim for an antibody genus found to satisfy both written description and enablement requirement (Teva v Eli Lilly)

Never Too Late: If you missed the IPKat last week!

EPO pharma case law trends 2025: Antibodies and biologics

Freedom to operate versus patentability in biotech: What the difference is and why it matters

Epitope claims stand firm: Board of Appeal upholds functional antibody patent despite insufficiency attack (T 0326/22)

Will functional antibody inventions find new life in the US with mean-plus-function claims? (Ex parte Chamberlain, Appeal No. 2022-001944)

Broad functional claiming at the EPO (T 0835/21)